Research Article

An Open-Label Pilot Study to Assess the Efficacy and Safety of Virgin Coconut Oil in Reducing Visceral Adiposity

Table 4

Levels for electrolytes, glucose, renal function tests, and liver function tests to assess for safety in 16 volunteers at week one and week six of study.

ParametersWeek one mean (SD)Week six mean (SD)Mean difference (SD)95% Confidence interval 𝑃 value

Sodium (mmol/L)138.75140.25−1.50 (4.62)−3.96, 0.96.21
Potassium (mmol/L)4.194.32−0.12 (0.40)−0.34, 0.09.23
Calcium (mmol/L)2.342.310.03 (0.17)−0.06, 0.12.53
Phosphate (mmol/L)1.241.180.06 (0.21)−0.05, 0.17.27
Uric acid (mmol/L)276.56257.1219.44 (37.75)−0.68, 39.55.06
Glucose (mmol/L)4.584.400.18 (0.56)−0.12, 0.48.21
Urea (mmol/L)4.394.380.01 (1.08)−0.56, 0.59.96
Creatinine (μmol/L)88.6282.626.00 (5.19)3.23, 8.76<.001
Albumin (g/dL)44.6244.500.12 (2.09)−0.99, 1.24.80
Total bilirubin (μmol/L)7.878.25−0.37 (3.50)−2.24, 1.49.67
AST (U/L)21.0619.311.75 (3.59)−0.16, 3.66.07
ALT (U/L)26.5623.503.06 (4.40)0.72, 5.41.01
ALP (U/L)70.1971.19−1.00 (6.33)−4.37, 2.37.54

* 𝑃 value is significant when 𝑃 < . 0 5 , SD = standard deviation.